CORESTEMCHEMON Inc. (KOSDAQ:166480)
South Korea · Delayed Price · Currency is KRW 3,865.00
+200.00 (5.46%)
At close: Jan 28, 2026
CORESTEMCHEMON Market Cap
CORESTEMCHEMON has a market cap or net worth of 176.33 billion as of January 29, 2026. Its market cap has increased by 86.56% in one year.
Market Cap
176.33B
Enterprise Value
223.90B
Revenue
20.13B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,865.00
Market Cap Chart
Since June 26, 2015, CORESTEMCHEMON's market cap has decreased from 653.85B to 176.33B, a decrease of -73.03%. That is a compound annual growth rate of -11.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 171.45B | 109.15% |
| Dec 30, 2025 | 81.98B | -13.27% |
| Dec 30, 2024 | 94.52B | -34.79% |
| Dec 28, 2023 | 144.95B | -43.25% |
| Dec 29, 2022 | 255.40B | -13.00% |
| Dec 30, 2021 | 293.58B | -19.49% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Prestige Biologics | 233.26B |
| Ensol Biosciences | 211.85B |
| Kangstem Biotech | 202.22B |
| Bio Solution | 192.90B |
| curacle co.,ltd. | 186.77B |
| ViGenCell | 169.94B |
| QuadMedicine | 169.55B |
| TiumBio | 168.05B |